HEALTHJul 6 · 13:37 UTCSTAT NEWSMeghana Keshavan

STAT+: Four major biotech updates to catch up on

The article highlights four biotech updates: Medicare proposing cuts to 340B payments, Republicans advocating for diversity in clinical trials, former surgeon general Jerome Adams advising on peptides regulation, and Novartis acquiring Myricx Bio for $1.1 billion to expand its cancer drug development. Anthropic CEO Dario Amodei expresses cautious optimism about AI's role in biotechnology.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

MedicareorganizationRepublicansorganizationJerome Adamspersonpeptides regulationtopicNovartisorganizationMyricx BioorganizationDario AmodeipersonAnthropicorganization

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHMay 26 · 13:50 UTC
STAT+: Five biotech news updates to stay on top of today
BUSINESSJun 29 · 08:30 UTC
Opinion: STAT+: The U.S.-China biotech crackdown may hurt the scientists America needs the most
SCIENCEJun 18 · 07:01 UTC
HARVEST: Biotech reset
HEALTHJun 11 · 12:05 UTC
STAT+: ‘Synthetic lethality’ could trigger another round of biotech M&A
TECHNOLOGYJul 6 · 08:30 UTC
STAT+: I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learned